IRVINE, Calif. — Ista Pharmaceuticals initiated a new phase 3 program designed to evaluate its proprietary formulation of Remura dry eye solution, the company announced in a press release. Ista will ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback